# CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clo26-092-real-world-use-of-eflapegrastim-in-14-day-chemotherapy-cycles-dose/

## Facts

| Field | Value |
| --- | --- |
| Author Names | L. S. Schwartzberg,Jeffrey Crawford,John Baird,Kenneth D. Crist,Vincent Marino,Neil Shah,Howard Franklin |
| Citations | 0 |
| DOI | 10.6004/jnccn.2025.7407 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7141029933 |
| PMID | 41911759 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Jeffrey Crawford](https://scholariq.org/researchers/jeffrey-crawford/)

## Paper journal

- [Journal of the National Comprehensive Cancer Network](https://scholariq.org/journals/journal-of-the-national-comprehensive-cancer-network/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.